Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Dr. Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Post-Doctorate | Shenzhen University | India

Dr. Shabnam Anjum is a postdoctoral researcher at Shenzhen University with a strong research footprint in biomaterials, nanofibrous scaffolds, extracellular vesicles, and regenerative medicine. Her work focuses extensively on the design, fabrication, and optimization of nanofibers, nanoparticles, microspheres, and hydrogels for tissue regeneration, particularly targeting bone, tendon, and ligament repair. She has contributed significantly to the advancement of electrospinning-based nanofibrous scaffolds, developing bioinspired core–shell systems, multifunctional drug-delivery constructs, and biomimetic matrices capable of modulating osteogenic and osteoclastic activity. Her publications in high-impact journals, including ACS Nano, Materials Today Bio, Frontiers in Bioengineering and Biotechnology, International Journal of Biological Macromolecules, and International Journal of Molecular Sciences, highlight her expertise in biomaterials, stem cell–derived extracellular vesicles, nanostructured drug-delivery systems, and regenerative therapeutics. She has authored influential review articles and innovative research papers demonstrating optimized electrospinning strategies, bioactive scaffold architectures, and decellularized matrix-based regenerative platforms. Her published findings collectively record 250 Scopus citations, 9 documents, and an h-index of 7. Dr. Shabnam Anjum’s emerging research pipeline includes cutting-edge studies on extracellular vesicle engineering, spatiotemporal therapeutic delivery, and osteoporotic bone regeneration. Her technical strengths span electrospinning, nanoparticle synthesis, advanced material characterization, microCT analysis, western blotting, qPCR, flow cytometry, and comprehensive biological evaluations. She has presented her research at prestigious scientific events such as the Chinese Biomaterials Conference and has actively engaged in global scientific webinars covering cancer research, stem cell biology, and precision medicine. She has also contributed to the scientific community through participation in specialized training programs on nanomaterials, animal experimentation, and polymer processing. Her research has been recognized through notable scholarships and academic distinctions, reflecting her dedication to innovative biomaterial development and regenerative therapy. Dr. Shabnam Anjum’s contributions continue to support advancements in nanotechnology-enabled regenerative medicine, positioning her as a promising researcher in the fields of tissue engineering, biomaterials design, and therapeutic nanotechnology.

Profiles: Scopus | Google Scholar | ResearchGate | Sci Profiles | Scilit | Loop

Featured Publications

1. Anjum, S., Rahman, F., Pandey, P., Arya, D. K., Alam, M., Rajinikanth, P. S., & Ao, Q. (2022). Electrospun biomimetic nanofibrous scaffolds: A promising prospect for bone tissue engineering and regenerative medicine. International Journal of Molecular Sciences, 23(16), 9206. https://doi.org/10.3390/ijms23169206

2. Kanaujiya, S., Arya, D. K., Pandey, P., Singh, S., Pandey, G., Anjum, S., … Rajinikanth, P. S. (2024). Resveratrol-ampicillin dual-drug loaded polyvinylpyrrolidone/polyvinyl alcohol biomimic electrospun nanofiber enriched with collagen for efficient burn wound repair. International Journal of Nanomedicine, 19, 5397–5418. https://doi.org/10.2147/IJN.S464046

3. Anjum, S., Wang, Y., Xin, Y., Li, X., Li, T., Zhang, H., Quan, L., Li, Y., Arya, D. K., … Ao, Q. (2024). Bioinspired core-shell nanofiber drug-delivery system modulates osteogenic and osteoclast activity for bone tissue regeneration. Materials Today Bio, 26, 101088. https://doi.org/10.1016/j.mtbio.2024.101088

4. Anjum, S., Li, T., Saeed, M., & Ao, Q. (2024). Exploring polysaccharide and protein-enriched decellularized matrix scaffolds for tendon and ligament repair: A review. International Journal of Biological Macromolecules, 254, 127891. https://doi.org/10.1016/j.ijbiomac.2023.127891

5. Arya, D. K., Deshpande, H., Kumar, A., Chidambaram, K., Pandey, P., Anjum, S., … Pandey, G. (2024). HER-2 receptor and αvβ3 integrin dual-ligand surface-functionalized liposome for metastatic breast cancer therapy. Pharmaceutics, 16(9), 1128. https://doi.org/10.3390/pharmaceutics16091128

Gert Fricker | Drug Delivery | Excellence in Research Award

Prof. Dr. Gert Fricker | Drug Delivery | Excellence in Research Award

Diretor at University of Heidelberg, Germany

Prof. Dr. Gert Fricker is Director of the Institute of Pharmacy and Molecular Biotechnology at Heidelberg University, Germany, where he also leads the Department of Pharmaceutical Technology and Biopharmacy. He earned his Ph.D. from the University of Freiburg with a focus on transcellular bile acid transport, followed by a habilitation in Experimental Medicine. His career spans academia and industry, including key roles at Sandoz Pharma AG and as CEO of the Steinbeis-Technology Transfer Center for Biopharmacy and Analytics. A pioneer in drug delivery systems, Prof. Fricker co-founded Heidelberg Delivery Technologies GmbH to advance oral peptide and protein therapeutics. His research centers on drug transport across biological barriers, ABC transporters, and drug formulation strategies. He has authored over 250 peer-reviewed publications, contributed to more than 60 books, and holds 14 patent applications. Among his accolades are the Phoenix Pharmacy Science Awards, the Dietrich-Schmähl Award, and the APV Research Award for outstanding pharmaceutical research.

Professional Profile:

SCOPUS

ORCID

🏆 Summary of Suitability: Prof. Dr. Gert Fricker Nomination for the Excellence in Research Award

Prof. Dr. Gert Fricker is an internationally distinguished pharmaceutical scientist whose decades-long contributions to drug delivery, biopharmaceutics, and membrane transport mechanisms have significantly advanced the field of pharmaceutical sciences. His profound academic rigor, interdisciplinary leadership, and translational impact make him an exceptional candidate for the Excellence in Research Award.

🎓 Education

  • 🧪 University of Freiburg, Germany (1975–1986)
    ➤ Studied Chemistry and Medicine

  • 📜 Ph.D. in Experimental Medicine (1986)
    ➤ Thesis: Transcellular Transport of Bile Acids in the Liver

  • 📘 Habilitation (1993)
    ➤ Field: Experimental Medicine
    ➤ Thesis: Pathomechanisms of Obstructive Cholestasis and Estradiol-Induced Intrahepatic Cholestasis

💼 Professional Experience

  • 🧬 Postdoctoral Fellow, Clinical Pharmacology, University Hospital Zürich, Switzerland (1986–1988)

  • 🧪 Research Scientist, Drug Delivery Systems, Sandoz Pharma AG, Basel, Switzerland (1988–1995)

  • 👨‍🏫 Professor, Institut für Pharmazeutische Technologie und Biopharmazie, University of Heidelberg (1995–2002)

  • 🎓 Director, Institut für Pharmazeutische Technologie und Biopharmazie, University of Heidelberg (1997–2002)

  • 🧫 Director, Institute of Pharmacy and Molecular Biotechnology, Faculty of Biosciences, University of Heidelberg (since 2002)

  • 🧪 CEO, Steinbeis Technology Transfer Center for Biopharmacy and Analytics, Heidelberg (since 1998)

  • 💊 Co-founder & Partner, Heidelberg Delivery Technologies GmbH (HeiDelTec) (since 2017)

🔬 Research Interests

  • 🧠 Drug transport across the Blood-Brain Barrier (BBB)

  • 🏥 Hepatic and membrane transport mechanisms

  • 💊 ABC transporters, drug absorption enhancement

  • 🎯 Targeted drug delivery and pharmaceutical formulations

🏆 Awards & Honors

  • 🧪 Phoenix Pharmacy Science Awards (2003, 2008)
    ➤ For outstanding scientific contributions in pharmaceutical technology and pharmacology

  • 🎗️ Dietrich-Schmähl Award (2003)
    ➤ From the Central European Society for Anticancer Drug Research

  • 🧫 APV Research Award (1998)
    ➤ Association of Pharmaceutical Technology for excellence in pharmacy

📚Publication Top Notes

Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier

Cited : 2

Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer’s Disease Is Associated with Activation of HIF-1 Signaling Pathway

Cited : 6

Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease

Cited : 9